Safety and tolerability of benznidazole in older patients with chronic Chagas disease
Background: Current guidelines recommend treating chronic Chagas disease (CD) with benznidazole up to 50 years of age, with individualized decisions in older individuals due to limited safety data. We aimed to compare the safety, tolerability and long-term outcomes of benznidazole in individuals abo...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2026-05-01
|
| Reeks: | Travel Medicine and Infectious Disease |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S1477893926000311 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|